Sudarshan Chempharma India Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
as on 15-05-2024
- Paid Up Capital ₹ 0.50 M
as on 15-05-2024
- Company Age 13 Year, 6 Months
- Last Filing with ROC 31 Mar 2015
- Revenue %
(FY 2015)
- Profit -229.98%
(FY 2015)
- Ebitda -229.98%
(FY 2015)
- Net Worth -4.60%
(FY 2015)
- Total Assets -0.70%
(FY 2015)
About Sudarshan Chempharma India
- CIN/LLPIN
U24100MH2011PLC218890
- Company No.
218890
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
21 Jun 2011
- Date of AGM
30 Sep 2015
- Date of Balance Sheet
31 Mar 2015
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Sudarshan Chempharma India?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Hemal Mehta  | Director | 21-Jun-2011 | Current |
| Sachin Mehta | Director | 21-Jun-2011 | Current |
| Devangi Mehta | Director | 19-Mar-2012 | Current |
Financial Performance and Corporate Structure Insights of Sudarshan Chempharma India.
Sudarshan Chempharma India Limited, for the financial year ended 2015, experienced no change in revenue, with a 0% increase. The company also saw a substantial fall in profitability, with a 229.98% decrease in profit. The company's net worth dipped by a decrease of 4.6%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Sudarshan Chempharma India?
In 2015, Sudarshan Chempharma India had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Sudarshan Solvents Industries LimitedActive 13 years 6 monthsSachin Mehta and Hemal Mehta are mutual person
Sudarshan Pharma Industries LimitedActive 16 years 4 monthsSachin Mehta and Hemal Mehta are mutual person
Sudarshan Chempharma India LlpActive 8 years 11 monthsSachin Mehta and Hemal Mehta are mutual person
- Life Science Chemical Private LimitedActive 1 year 3 months
Sachin Mehta and Hemal Mehta are mutual person
- Sudarshan Maven Pharma Private LimitedActive 3 months 24 days
Sachin Mehta and Hemal Mehta are mutual person
- Sudarshan Pharma Lifescience Private LimitedActive 3 years 9 months
Sachin Mehta and Hemal Mehta are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Sudarshan Chempharma India?
Unlock and access historical data on people associated with Sudarshan Chempharma India, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Sudarshan Chempharma India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sudarshan Chempharma India's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
